Search results
What's keeping the U.S. from allowing better sunscreens?
NBC Universal via AOL· 1 hour agoThe FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is...
West Allis Hale girls soccer embodies 'never quit' attitude of assistant coach
Milwaukee Journal Sentinel via Yahoo Sports· 14 hours agoI mean they're just...I get a couple hours each day." Huskies raise funds for 'Strain for the Brain'...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
ILD Not Increased With MTX in Patients With Dermatomyositis
Medscape· 2 days agoTreatment with methotrexate was not associated with an increased risk for interstitial lung disease...
Harry Jowsey reveals skin cancer diagnosis at age 26 — here’s what to know about the ‘scary’ disease
NY Post via Yahoo News· 7 days agoGetty Images The Centers for Disease Control and Prevention say that sun safety is key to reduce the...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoIn addition to our ongoing phase 3 studies in adjuvant melanoma and adjuvant non-small cell lung cancer, a phase 2 free study has started in neoadjuvant...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna is co-developing mRNA-4157 with Merck. Since the onset of 2024, the companies have initiated...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 2 days agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options for patients ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoThis year, they began studies in patients with kidney cancer, bladder cancer and a common form of...
Castle Biosciences Builds Skin Cancer Assay Data, Eyes Future Expansion as Q1 Sales Jump 74 Percent
GenomeWeb News· 22 hours agoDespite facing challenges in maintaining coverage by the US Centers for Medicare and Medicaid Services for its newer squamous cell carcinoma< ...